{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T08:11:16Z","timestamp":1770451876680,"version":"3.49.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["2632018PY13"],"award-info":[{"award-number":["2632018PY13"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012246","name":"Priority Academic Program Development of Jiangsu Higher Education Institutions","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012246","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018621","name":"Program for Changjiang Scholars and Innovative Research Team in University","doi-asserted-by":"publisher","award":["IRT_15R63"],"award-info":[{"award-number":["IRT_15R63"]}],"id":[{"id":"10.13039\/501100018621","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003512","name":"State Administration of Foreign Experts Affairs","doi-asserted-by":"publisher","award":["B18056"],"award-info":[{"award-number":["B18056"]}],"id":[{"id":"10.13039\/501100003512","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Biomaterialia"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.actbio.2018.07.018","type":"journal-article","created":{"date-parts":[[2018,7,10]],"date-time":"2018-07-10T20:59:53Z","timestamp":1531256393000},"page":"268-281","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":62,"special_numbering":"C","title":["Hypericin-functionalized graphene oxide for enhanced mitochondria-targeting and synergistic anticancer effect"],"prefix":"10.1016","volume":"77","author":[{"given":"Chao","family":"Han","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Can","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianguang","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huijun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingyi","family":"Kong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.actbio.2018.07.018_b0005","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/nrd3137","article-title":"Targeting mitochondria for cancer therapy","volume":"9","author":"Fulda","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.actbio.2018.07.018_b0010","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.tips.2012.03.010","article-title":"Mitochondrial pharmacology","volume":"33","author":"Smith","year":"2012","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.actbio.2018.07.018_b0015","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1021\/cb400821p","article-title":"Molecular vehicles for mitochondrial chemical biology and drug delivery","volume":"9","author":"Jean","year":"2014","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.actbio.2018.07.018_b0020","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.actbio.2015.09.033","article-title":"Tumor mitochondria-targeted photodynamic therapy with a translocator protein (TSPO)-specific photosensitizer","volume":"28","author":"Zhang","year":"2015","journal-title":"Acta Biomater."},{"key":"10.1016\/j.actbio.2018.07.018_b0025","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1002\/adhm.201600212","article-title":"A highly photostable hyperbranched polyglycerol-based NIR fluorescence nanoplatform for mitochondria-specific cell imaging","volume":"5","author":"Dong","year":"2016","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.actbio.2018.07.018_b0030","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1089\/ars.2011.3969","article-title":"Mitochondria-targeted small molecule therapeutics and probes","volume":"15","author":"Smith","year":"2011","journal-title":"Antioxid. Redox. Signal."},{"key":"10.1016\/j.actbio.2018.07.018_b0035","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/nrm2952","article-title":"Mitochondria and cell death: outer membrane permeabilization and beyond","volume":"11","author":"Tait","year":"2010","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.actbio.2018.07.018_b0040","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.biomaterials.2017.05.016","article-title":"Validation of the use of an artificial mitochondrial reporter DNA vector containing a Cytomegalovirus promoter for mitochondrial transgene expression","volume":"136","author":"Yamada","year":"2017","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2018.07.018_b0045","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1007\/s12274-017-1728-7","article-title":"Mitochondria-targeting self-assembled nanoparticles derived from triphenylphosphonium-conjugated cyanostilbene enable site-specific imaging and anticancer drug delivery","volume":"11","author":"Kim","year":"2018","journal-title":"Nano Res."},{"key":"10.1016\/j.actbio.2018.07.018_b0050","doi-asserted-by":"crossref","first-page":"16288","DOI":"10.1073\/pnas.1210096109","article-title":"Engineering of blended nanoparticle platform for delivery of mitochondria-acting therapeutics","volume":"109","author":"Marrache","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.actbio.2018.07.018_b0055","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1039\/C4SC01963F","article-title":"The energy blocker inside the power house: mitochondria targeted delivery of 3-bromopyruvate","volume":"6","author":"Marrache","year":"2014","journal-title":"Chem. Sci."},{"key":"10.1016\/j.actbio.2018.07.018_b0060","doi-asserted-by":"crossref","first-page":"7584","DOI":"10.1021\/am5090226","article-title":"Dual drug conjugated nanoparticle for simultaneous targeting of mitochondria and nucleus in cancer cells","volume":"7","author":"Mallick","year":"2015","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.actbio.2018.07.018_b0065","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1039\/c3cc48740g","article-title":"Conjugation of vitamin E analog \u03b1-TOS to Pt(IV) complexes for dual-targeting anticancer therapy","volume":"50","author":"Suntharalingam","year":"2014","journal-title":"Chem. Commun."},{"key":"10.1016\/j.actbio.2018.07.018_b0070","doi-asserted-by":"crossref","first-page":"5334","DOI":"10.1021\/ol202139z","article-title":"Synthesis and evaluation of a fluorescent ritterazine-cephalostatin hybrid","volume":"13","author":"Kumar","year":"2011","journal-title":"Org. Lett."},{"key":"10.1016\/j.actbio.2018.07.018_b0075","doi-asserted-by":"crossref","first-page":"17415","DOI":"10.1002\/chem.201502543","article-title":"Fluorescent coumarin-artemisinin conjugates as mitochondria targeting theranostic probes for enhanced anticancer activities","volume":"21","author":"Zhang","year":"2015","journal-title":"Chem. Eur. J."},{"key":"10.1016\/j.actbio.2018.07.018_b0080","doi-asserted-by":"crossref","first-page":"5022","DOI":"10.1021\/acs.jmedchem.6b00408","article-title":"Probing the anticancer action of oridonin with fluorescent analogues: visualizing subcellular localization to mitochondria","volume":"59","author":"Xu","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.actbio.2018.07.018_b0085","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nrd4510","article-title":"The re-emergence of natural products for drug discovery in the genomics era","volume":"14","author":"Harvey","year":"2015","journal-title":"Nat. Rev. Drug Disco."},{"issue":"2016","key":"10.1016\/j.actbio.2018.07.018_b0090","first-page":"629","article-title":"Natural products as sources of new drugs from 1981 to 2014","volume":"79","author":"Newman","year":"1981","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.actbio.2018.07.018_b0095","article-title":"Glycyrrhetinic acid functionalized graphene oxide for mitochondria targeting and cancer treatment in vivo","volume":"1703306","author":"Zhang","year":"2017","journal-title":"Small"},{"key":"10.1016\/j.actbio.2018.07.018_b0100","doi-asserted-by":"crossref","first-page":"10562","DOI":"10.1039\/c3nr02724d","article-title":"Hypericin-loaded lipid nanocapsules for photodynamic cancer therapy in vitro","volume":"5","author":"Barras","year":"2013","journal-title":"Nanoscale"},{"key":"10.1016\/j.actbio.2018.07.018_b0105","doi-asserted-by":"crossref","first-page":"9484","DOI":"10.1021\/ja961783k","article-title":"Hypericin-induced cell photosensitization involves an intracellular pH decrease","volume":"118","author":"Sureau","year":"1996","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.actbio.2018.07.018_b0110","doi-asserted-by":"crossref","first-page":"427","DOI":"10.3109\/10717544.2013.873838","article-title":"Sodium cholate, a solubilizing agent for the necrosis avid radioiodinated hypericin in rabbits with acute myocardial infarction","volume":"22","author":"Cona","year":"2015","journal-title":"Drug Deliv."},{"key":"10.1016\/j.actbio.2018.07.018_b0115","doi-asserted-by":"crossref","first-page":"18398","DOI":"10.1038\/srep18398","article-title":"Hypericin-photodynamic therapy induces human umbilical vein endothelial cell apoptosis","volume":"5","author":"Zhang","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.actbio.2018.07.018_b0120","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jphotobiol.2013.05.010","article-title":"Hypericin encapsulated in solid lipid nanoparticles: phototoxicity and photodynamic efficiency","volume":"125","author":"Lima","year":"2013","journal-title":"J. Photochem. Photobiol. B"},{"key":"10.1016\/j.actbio.2018.07.018_b0125","doi-asserted-by":"crossref","first-page":"e697","DOI":"10.1038\/cddis.2013.219","article-title":"Hypericin-photodynamic therapy leads to interleukin-6 secretion by HepG2 cells and their apoptosis via recruitment of BH3 interacting-domain death agonist and caspases","volume":"4","author":"Barathan","year":"2013","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.actbio.2018.07.018_b0130","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.4161\/auto.25399","article-title":"ROS-induced autophagy in cancer cells assists in evasion from determinants of immunogenic cell death","volume":"9","author":"Garg","year":"2013","journal-title":"Autophagy"},{"key":"10.1016\/j.actbio.2018.07.018_b0135","doi-asserted-by":"crossref","first-page":"793","DOI":"10.2174\/092986712799034842","article-title":"Molecular response to hypericin-induced photodamage","volume":"19","author":"Krammer","year":"2012","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.actbio.2018.07.018_b0140","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0302-2838(02)00402-5","article-title":"Fluorescence detection of bladder cancer: a review","volume":"42","author":"D\u2019Hallewin","year":"2002","journal-title":"Eur. Urol."},{"key":"10.1016\/j.actbio.2018.07.018_b0145","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/jps.24230","article-title":"Evaluation of hypericin: effect of aggregation on targeting biodistribution","volume":"104","author":"Liu","year":"2015","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.actbio.2018.07.018_b0150","first-page":"129","article-title":"Radiolabeled iodohypericin as tumor necrosis avid tracer: diagnostic and therapeutic potential","volume":"131","author":"de Putte","year":"2012","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.actbio.2018.07.018_b0155","doi-asserted-by":"crossref","first-page":"127","DOI":"10.7150\/thno.5790","article-title":"Sequential systemic administrations of combretastatin A4 phosphate and radioiodinated hypericin exert synergistic targeted theranostic effects with prolonged survival on SCID mice carrying bifocal tumor xenografts","volume":"3","author":"Li","year":"2013","journal-title":"Theranostics"},{"key":"10.1016\/j.actbio.2018.07.018_b0160","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0304-3835(03)00207-6","article-title":"Specificity of photosensitizer accumulation in undifferentiated versus differentiated colon carcinoma cells","volume":"196","author":"Siboni","year":"2003","journal-title":"Cancer Lett."},{"key":"10.1016\/j.actbio.2018.07.018_b0165","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.actbio.2017.11.036","article-title":"Combinational siRNA delivery using hyaluronic acid modified amphiphilic polyplexes against cell cycle and phosphatase proteins to inhibit growth and migration of triple-negative breast cancer cells","volume":"66","author":"Parmar","year":"2017","journal-title":"Acta Biomater."},{"key":"10.1016\/j.actbio.2018.07.018_b0170","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.actbio.2017.12.003","article-title":"An implantable depot capable of in situ generation of micelles to achieve controlled and targeted tumor chemotherapy","volume":"67","author":"Luo","year":"2018","journal-title":"Acta Biomater."},{"key":"10.1016\/j.actbio.2018.07.018_b0175","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.bbabio.2004.05.012","article-title":"the mechanism of mitochondrial permeability transition induction by glycyrrhetinic acid","volume":"1658","author":"Fiore","year":"2004","journal-title":"Biochim. Biophys. Acta Bioenerg."},{"key":"10.1016\/j.actbio.2018.07.018_b0180","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1002\/hep.22239","article-title":"Prevention of free fatty acid-induced hepatic lipotoxicity by 18beta-glycyrrhetinic acid through lysosomal and mitochondrial pathways","volume":"47","author":"Wu","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.actbio.2018.07.018_b0185","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.actbio.2017.12.028","article-title":"Redox-responsive polymeric micelles formed by conjugating gambogic acid with bioreducible poly(amido amine)s for the co-delivery of docetaxel and MMP-9 shRNA","volume":"68","author":"Kang","year":"2018","journal-title":"Acta Biomater."},{"key":"10.1016\/j.actbio.2018.07.018_b0190","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.actbio.2017.12.033","article-title":"Multifunctional nanoparticles as somatostatin receptor-targeting delivery system of polyaniline and methotrexate for combined chemo\u2013photothermal therapy","volume":"68","author":"Nguyen","year":"2018","journal-title":"Acta Biomater."},{"key":"10.1016\/j.actbio.2018.07.018_b0195","first-page":"250","article-title":"Photodynamic therapy of cancer: an update","volume":"61","author":"Agostinis","year":"2011","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.actbio.2018.07.018_b0200","doi-asserted-by":"crossref","first-page":"4386","DOI":"10.1002\/adfm.201400221","article-title":"Multifunctional graphene oxide-based triple stimuli-responsive nanotheranostics","volume":"24","author":"Chen","year":"2014","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.actbio.2018.07.018_b0205","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1126\/science.1095833","article-title":"Drug delivery systems: entering the mainstream","volume":"303","author":"Allen","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.actbio.2018.07.018_b0210","doi-asserted-by":"crossref","first-page":"3364","DOI":"10.1038\/ncomms4364","article-title":"ATP-triggered anticancer drug delivery","volume":"5","author":"Mo","year":"2014","journal-title":"Nat. Comm."},{"key":"10.1016\/j.actbio.2018.07.018_b0215","doi-asserted-by":"crossref","first-page":"6608","DOI":"10.1021\/acsami.7b16910","article-title":"Design and development of graphene oxide nanoparticle\/chitosan hybrids showing pH-sensitive surface charge-reversible ability for efficient intracellular doxorubicin delivery","volume":"10","author":"Zhao","year":"2018","journal-title":"ACS Appl. Mater. Inter."},{"key":"10.1016\/j.actbio.2018.07.018_b0220","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1039\/C6TB03062A","article-title":"Electron microscopy for inorganic-type drug delivery nanocarriers for antitumoral applications: what does it reveal?","volume":"5","author":"Baeza","year":"2017","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.actbio.2018.07.018_b0225","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1039\/C2CS35342C","article-title":"Nano-graphene in biomedicine: theranostic applications","volume":"42","author":"Yang","year":"2013","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.actbio.2018.07.018_b0230","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1056\/NEJMp1101548","article-title":"Development of novel combination therapies","volume":"364","author":"Woodcock","year":"2011","journal-title":"New Eng. J. Med."},{"key":"10.1016\/j.actbio.2018.07.018_b0235","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1124\/mi.7.4.8","article-title":"Optimizing combination chemotherapy by controlling drug ratios","volume":"7","author":"Mayer","year":"2007","journal-title":"Mol. Interv."},{"key":"10.1016\/j.actbio.2018.07.018_b0240","doi-asserted-by":"crossref","first-page":"5223","DOI":"10.1016\/j.biomaterials.2011.03.060","article-title":"Redox-responsive nanocapsules for intracellular protein delivery","volume":"32","author":"Zhao","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2018.07.018_b0245","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.nantod.2012.12.003","article-title":"Degradable polymeric nanocapsule for efficient intracellular delivery of a high molecular weight tumor-selective protein complex","volume":"8","author":"Zhao","year":"2013","journal-title":"Nano Today"},{"key":"10.1016\/j.actbio.2018.07.018_b0250","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1039\/C7NR07603G","article-title":"Vibrating droplet generation to assemble zwitterion-coated gold-graphene oxide stealth nanovesicles for effective pancreatic cancer chemo-phototherapy","volume":"10","author":"Thapa","year":"2018","journal-title":"Nanoscale"},{"key":"10.1016\/j.actbio.2018.07.018_b0255","doi-asserted-by":"crossref","first-page":"5914","DOI":"10.1158\/0008-5472.CAN-16-1248","article-title":"Finally, an apoptosis-targeting therapeutic for cancer","volume":"76","author":"Croce","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.actbio.2018.07.018_b0260","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1038\/onc.2014.96","article-title":"Molecular mechanisms of cell death: central implication of ATP synthase in mitochondrial permeability transition","volume":"34","author":"Bonora","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.actbio.2018.07.018_b0265","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1126\/science.278.5336.294","article-title":"Caspase-3-generated fragment of gelsolin: effector of morphological change in apoptosis","volume":"278","author":"Kothakota","year":"1997","journal-title":"Science"}],"container-title":["Acta Biomaterialia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706118304124?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706118304124?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T17:09:08Z","timestamp":1761671348000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1742706118304124"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":53,"alternative-id":["S1742706118304124"],"URL":"https:\/\/doi.org\/10.1016\/j.actbio.2018.07.018","relation":{},"ISSN":["1742-7061"],"issn-type":[{"value":"1742-7061","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hypericin-functionalized graphene oxide for enhanced mitochondria-targeting and synergistic anticancer effect","name":"articletitle","label":"Article Title"},{"value":"Acta Biomaterialia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actbio.2018.07.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}